Combination of Rapamycin and Imatinib in Treating Refractory Chronic Myeloid Leukemia Myeloid Blast Crisis:a Case Report<sup>025B3;</sup>

Your Location：

Home >

Browse articles >

Combination of Rapamycin and Imatinib in Treating Refractory Chronic Myeloid Leukemia Myeloid Blast Crisis:a Case Report^025B3;

null Issue 2, Pages: 127-128(2013)

Updated：2024-04-10

- Combination of Rapamycin and Imatinib in Treating Refractory Chronic Myeloid Leukemia Myeloid Blast Crisis:a Case Report^025B3;
- Affiliations：
  
  1. Key Laboratory of Thrombosis and Hemostasis of Ministry of Health
  2. Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University,Suzhou,China,215006
- Author bio：
- Funds：
- DOI：
  CLC：
- Published Online：26 June 2013，
  
  Published：2013
- Accepted：
Scan QR Code
Jing Xie, Xiang Zhang, Bao-zhi Fang, et al. Combination of Rapamycin and Imatinib in Treating Refractory Chronic Myeloid Leukemia Myeloid Blast Crisis:a Case Report^025B3;[J]. Null, 2013, (2): 127-128.
DOI：

Jing Xie, Xiang Zhang, Bao-zhi Fang, et al. Combination of Rapamycin and Imatinib in Treating Refractory Chronic Myeloid Leukemia Myeloid Blast Crisis:a Case Report^025B3;[J]. Null, 2013, (2): 127-128. DOI：

Supported by Key Provincial Talents Program of Jiangsu (H201126)

and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).

Views

883

Downloads

CSCD

Alert me when the article has been cited

Submit

Publicity Resources

No data

Related Author

No data

Related Institution

No data

⁰

Combination of Rapamycin and Imatinib in Treating Refractory Chronic Myeloid Leukemia Myeloid Blast Crisis:a Case Report025B3;